563 results on '"Jillella, Anand"'
Search Results
2. Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?
3. A HIGHLY SUCCESSFUL MODEL TO DECREASE RACIAL DISPARITIES AND INCREASE ACCESS TO AUTOLOGOUS TRANSPLANTS AMONG AFRICAN AMERICANS WITH MULTIPLE MYELOMA – OUTREACH AND SATELLITE TRANSPLANT CLINICS
4. Assessing Outcomes in Patients with Multiple Myeloma Post-Autologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200mg/m2 versus 140mg/m2
5. Elevated Ferritin Prior to Collection and Mobilization May Predict Low Stem Cell Yield
6. Blood Product Support in Multiple Myeloma Patients Undergoing Autologous Bone Marrow Transplantation May Predict Improved Outcome.
7. CT-448 Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduces Racial Disparities
8. A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
9. A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia
10. P-466 Peripheral and severe autonomic neuropathy characterized by dizziness, orthostatic hypotension and weight loss caused by bortezomib
11. Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease
12. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
13. Homologous Recombination Deficiency (HRD) in Hematological Malignancies
14. Time to Abandon the Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy
15. A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial
16. Strategies to Optimize the Utilization of Stored Autologous Peripheral Blood Stem Cells for Second Transplantation in Multiple Myeloma
17. Incremental Clinically Relevant Information in 70 CLL Cases with Optical Genome Mapping: Going Beyond Karyotype and FISH
18. Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss
19. Optical Genome Mapping and Comprehensive Next Generation Sequencing Panel for Myeloid Cancers: New Era of Complimentary Profiling
20. Impact of Qualified Dedicated APL Leukemia Specialist and Simplified Treatment Algorithm on Early Deaths in APL, a Monocenter Experience
21. Unraveling Gene Fusions with Optical Genome Mapping in Hematological Malignancies: The Unexplored Terrain
22. Musculoskeletal Pain Syndrome in a Subset of APL Patients during Induction Therapy
23. Autologous Hematopoietic Stem Cell Transplantation Improves Survival in Patients with Multiple Myeloma and End Stage Renal Disease
24. Poster: CT-448 Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduces Racial Disparities
25. Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies
26. P-140: Outreach and satellite transplant clinics increase multiple myeloma (MM) transplant referrals and specifically transplant referrals of African American patients
27. Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduce Racial Disparities
28. Comparative Incidence of Relapse and Progression Free Survival in Morbidly Obese Vs. Non-Morbidly Obese Multiple Myeloma Patients Who Have Undergone Autologous Stem Cell Transplantations
29. Outcomes for Patients with Multiple Myeloma after Receipt of Melphalan 200mg/m2 Versus 140 Mg/m2 for Autologous Stem Cell Transplantation
30. Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
31. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
32. Predicting early blast transformation in chronic-phase chronic myeloid leukemia: Is immunophenotyping the missing link?
33. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism
34. Rates of Neutropenic Fever in Patients with Hematologic Malignant Diseases with Central Venous Access
35. Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting
36. The Increased Use of Diagnostic Studies over Time in Acute Myelogenous Leukemia Patients
37. Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML)
38. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)
39. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome
40. Light Chain–Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival
41. A Highly Successful Model to Decrease Racial Disparities and Increase Access to Autologous Transplants Among African Americans with Multiple Myeloma - Outreach and Satellite Transplant Clinics
42. Outcomes in Acute Lymphoid Leukemia Patients with Incomplete Hyper-CVAD Cycles
43. Are Pivotal CART Trials Representative of Population at Risk?
44. Improving Clinical Outcomes in APL: Weight Maintenance Strategies to Reduce Complications during Induction Therapy
45. Financial Trends of AML Patients over the Past Decade
46. Outcomes of Regimented Weight Monitoring on Morbidity and Mortality during AML Induction
47. Hidac Consolidation Cycles May Impede Stem Cell Transplant Planning for High-Risk Acute Myeloid Leukemia Patients
48. Academic Outreach and Collaboration with Community Oncology Practices to Enhance Referrals and Reduce Disparities in Hematological Malignancies
49. Serum Ferritin Levels Prior to Mobilization and Collection May Not Influence Stem Cell Yield
50. The Overuse of C. Difficile Testing Among Autologous Transplant Patients with Melphalan Conditioning: A Single Center Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.